-
JC-1 Mitochondrial Membrane Potential Assay Kit: Workflow &
2026-05-09
Unlock robust, ratiometric quantification of mitochondrial membrane potential for apoptosis and immunomodulation studies with the JC-1 Mitochondrial Membrane Potential Assay Kit. Learn how this kit streamlines workflows, enhances data reliability, and supports advanced applications in cancer research and beyond.
-
PCN Regulates Hippocampal CYPs and Mitigates Phenytoin Neuro
2026-05-08
This study uncovers a novel, PXR-independent mechanism by which Pregnenolone-16α-carbonitrile (PCN) suppresses hippocampal cytochrome P450 enzymes, reducing phenytoin-induced neurotoxicity via the glucocorticoid receptor. These findings shift the paradigm regarding PCN's action in neuroprotection and have implications for the management of antiepileptic drug side effects.
-
PBS Liposomes: Precision Controls for Macrophage Depletion A
2026-05-08
PBS Liposomes provide a robust, biologically inert control for in vivo macrophage depletion protocols, ensuring data integrity and reproducibility in immunological studies. By mimicking the uptake pathway of active clodronate liposomes without cytotoxicity, these control liposomes streamline comparative assessments and troubleshooting in macrophage-targeted workflows.
-
Multi-Omics Uncovers ARID1A-Dependent Melanoma Resistance Ne
2026-05-07
This study applies integrative multi-omics to reveal how ARID1A loss drives resistance to BRAF/MAPK inhibition in melanoma, identifying critical signaling rewiring and immune evasion mechanisms. The findings highlight new potential therapeutic targets and offer a systems-level framework for dissecting drug response networks in cancer biology.
-
Iptacopan Monotherapy in PNH: Clinical Efficacy and Research
2026-05-07
This phase 2 proof-of-concept study demonstrates that oral Iptacopan (LNP023) monotherapy achieves rapid, durable improvements in hemolytic markers, hemoglobin, and transfusion independence for patients with paroxysmal nocturnal hemoglobinuria (PNH). The findings validate targeted alternative pathway inhibition as a promising single-agent therapeutic approach and provide a framework for translational research and protocol optimization.
-
Novel Allosteric PDK4 Inhibitors for Metabolic Disease Thera
2026-05-06
This study introduces a new series of allosteric PDK4 inhibitors, led by compound 8c, which demonstrates potent in vitro and in vivo efficacy for metabolic diseases. The findings provide a validated drug scaffold and highlight metabolic pathway targeting as a promising therapeutic route.
-
Genotyping Kit for Target Alleles: Fast PCR from Diverse Sam
2026-05-06
Streamline genetic analysis of insects, tissues, fishes, and cells with APExBIO's Genotyping Kit for target alleles. This kit delivers rapid, single-tube DNA prep and robust PCR amplification—outperforming traditional phenol-based protocols for high-throughput molecular biology genotyping research.
-
CD28-ARS2-Driven PKM Splicing Enhances CD8+ T Cell Flexibili
2026-05-05
This study elucidates how the CD28-ARS2 signaling axis promotes alternative splicing of pyruvate kinase (PKM), favoring the PKM2 isoform in activated CD8+ T cells. These findings reveal a novel mechanism for metabolic adaptation critical to antitumor immunity, with implications for immunometabolic research and genetic engineering workflows.
-
Applied Workflows with Recombinant Mouse Macrophage Colony S
2026-05-05
Harness the precision of Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) without Tag from APExBIO for optimized macrophage differentiation, functional reprogramming, and disease modeling. This article translates recent bench breakthroughs into actionable protocols and troubleshooting strategies, ensuring robust, reproducible results in immunology and fibrosis research.
-
H-89 in Translational Osteometabolism: From Signal to Strate
2026-05-04
This thought-leadership piece synthesizes mechanistic breakthroughs in Wnt-driven osteogenesis with actionable guidance for translational researchers. It demonstrates how the selective PKA inhibitor H-89 from APExBIO enables precise dissection of cAMP-mediated signaling, offering protocol optimization and critical workflow parameters. Integrating recent advances in O-GlcNAcylation and metabolic rewiring, the article positions H-89 as an indispensable tool for next-generation studies in bone formation and metabolic disease.
-
Baicalin’s Emerging Role in Adult Neuroplasticity & Cancer R
2026-05-04
Explore how Baicalin, a flavone glycoside, uniquely unlocks adult neuroplasticity and modulates cancer pathways through KEAP1-NRF2/HO-1 pathway modulation. This article offers a deep dive into mechanistic insights and practical guidance for translational research.
-
Nirmatrelvir (PF-07321332): Mechanistic Insights for Antivir
2026-05-03
Explore the advanced mechanism and research applications of Nirmatrelvir (PF-07321332) as a SARS-CoV-2 3CL protease inhibitor. This article uniquely bridges molecular detail with practical assay considerations for antiviral therapeutics research.
-
Chlorpromazine HCl: Dopamine Receptor Antagonist in Advanced
2026-05-02
Chlorpromazine HCl uniquely bridges dopamine receptor antagonism with precision endocytic pathway blockade, making it indispensable for neuropharmacology and infection model workflows. By integrating evidence from bench and reference studies, this guide delivers actionable protocols and troubleshooting insights for maximizing assay reproducibility and experimental clarity.
-
Microglial Activation Drives Seizure Susceptibility after Ac
2026-05-01
This study provides new mechanistic insight into how microglial activation in the hippocampal CA1 region contributes to acute alcohol-induced seizure susceptibility. By dissecting the interplay between microglia, GABAergic interneurons, and glutamatergic neurons, the findings inform potential targets for modulating neuroinflammation and synaptic dysregulation in alcohol-related epilepsy.
-
Baicalin and KEAP1-NRF2/HO-1 Pathway Modulation in Research
2026-05-01
Baicalin, a high-purity flavone glycoside, is redefining translational research by enabling precise KEAP1-NRF2/HO-1 pathway modulation and TGF-β1/p-Smad3 inhibition. Its unique capacity to restore adult neuroplasticity and sensitize cancer cells underpins its value in advanced experimental workflows.